Antonio Gasbarrini to Neoplasm Staging
This is a "connection" page, showing publications Antonio Gasbarrini has written about Neoplasm Staging.
Connection Strength
0.317
-
Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort Study. Hepatology. 2018 10; 68(4):1232-1244.
Score: 0.110
-
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study. Liver Int. 2019 08; 39(8):1478-1489.
Score: 0.029
-
Metabolic disorders across hepatocellular carcinoma in Italy. Liver Int. 2018 11; 38(11):2028-2039.
Score: 0.027
-
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice. Hepatology. 2018 05; 67(5):1784-1796.
Score: 0.026
-
Assessment of preoperative nutritional status using BIA-derived phase angle (PhA) in patients with advanced ovarian cancer: Correlation with the extent of cytoreduction and complications. Gynecol Oncol. 2018 05; 149(2):263-269.
Score: 0.026
-
Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach. World J Gastroenterol. 2017 May 14; 23(18):3195-3204.
Score: 0.025
-
Watery stools and metabolic acidosis. Intern Emerg Med. 2017 Jun; 12(4):487-492.
Score: 0.025
-
Team work and cytopathology molecular diagnosis of solid pancreatic lesions. Dig Endosc. 2017 Sep; 29(6):657-666.
Score: 0.025
-
Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma. Oncotarget. 2017 Feb 28; 8(9):14408-14415.
Score: 0.025